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Abstract. Mitochondrial DNA's from the peripheral blood of 14 patients
with granulocytic leukemia contained a circular dimer form. No such structure
could be found in M DNA's from three patients with nonmalignant proliferations
of granulocytes. The frequency of the circular dimer form is reduced upon
treatment with antileukemic drugs. The above results suggest that a significant
relation exists between the formation and presence of the circular dimer M DNA
form and granulocytic leukemia in man.
We have previously reported that animal mitochondrial DNA (M DNA)
occurs in two complex forms1-3 in addition to the simple circular form with a
contour length of about 5 ,u. The circular dimer form a double-length circular
molecule1' 2 was found in human leukemic white cells along with the catenane
form,3 in which the single-length submolecules are connected to each other like
links in a chain. The presence of the circular dimer in the M DNA from the
three leukemic patients studied,2 and the absence of this form in the WI DNA
from normal mature human leukocytes,2 5 HeLa cells,3 sea urchin eggs,4 and
a variety of normal mammalian tissues,5 suggested to us that there might be a
correlation between the occurrence of the circular dimer and human leukemia.
We therefore carried out a more extensive study of the frequency of complex
M DNA forms in circulating leukocytes from patients with granulocytic leu-
kemia and, for comparison, from patients with nonleukemic leukopoietic dis-
orders. The M DNA's from 14 leukemic patients all contained circular dimers
(Fig. 1), whereas the M DNA's from three patients with normal, immature
myeloid cells contained none. In the course of this study we also found that
treatment with cytotoxic drugs substantially lowered the frequency of the
circular dimer. The above results together suggest that a significant relation
exists between the formation and presence of the abnormal M DNA form and
granulocytic leukemia in man.
Materials and Methods.-Chemicals: Optical grade CsCl was obtained from the
Harshaw Chemical Co. Ethidium bromide was a gift from Boots Pure Drug Co., Ltd.,
Nottingham, England. Sodium dodecylsulfate was obtained from the Matheson Co.
All other chemicals were of reagent grade.
Preparation of leukocyte M DNA: Whole-blood samples, 10-100 ml, were allowed
to settle at 40 for 2 to 20 hr. Buffy coats were drawn off and red cells were removed
l)y hemolysis for 20 sec with distilled water. The leukocytes were spun down at 1000 X g,
for 5 min in an International PR-1 centrifuge and resuspended in a tenfold volume of
homogenizing medium: 0.21 M mannitol; 0.07 M sucrose; 0.001 M Tris HCl, pH 7.5;
and 0.0001 M ethylenediaminetetraacetate (EDTA). The cells were homogenized with
a tight-fitting Teflon pestle until approximately 80% of the nuclei were liberated, as
observed in the light microscope. The homogenate was centrifuged at 1000 X g for 5
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.$7~~ ~~ Fin. 1.~-Electron micro-
~~ ~~ '~~~Ai graphs of M DNA isolated
±1 .<.:~~~~~~~g:from leukemic leukocytes.(a) Monomeric M DNA.
~~~~~~~~~(b) Circular dimer M DNA.
min. The supernatant was centrifuged at 15,000 X g for 15 min in a Sorvall SS-34
rotor to pellet the mitochondria. The pellet was resuspended in 5 ml of homogenizing
medium and placed on a step gradient containing equal volumes of 1.00 M, 1.50 M, and
1.75 M sucrose. The sucrose solutions contained 0.001 M Tris HCl, pH 7.5, and 0.0001
M EDTA. The tubes were centrifuged for 30 min at 20 krpm in a Spinco SW-25.1 or
SW-27 rotor. The buoyant material at the 1.00 M-1.50 M interface was removed with
a pipet, diluted fourfold with homogenizing medium, and pelleted. The mitochondrial
pellet was resuspended in 10 ml of 0.21 M mannitol, 0.07 M sucrose, 0.05 M Tris HCl,
pH 6.7, 0.025 M KCl, and 0.0025 M MgCl2. All of the foregoing operations were at 4°.
DNase I and RNase A (Sigma Chemical Co.), 100 jug each, were added and the mixture
incubated at 250 for 30 min. The reaction was quenched by the addition of EDTA, and
the temperature was lowered to 00. The mitochondria were pelleted and the DNA was
isolated after the addition of sodium dodecylsulfate, CsCl, and ethidium bromide (EB),
as described earlier." 2, 5 In most cases, both the upper and lower fluorescent bands
and the CsCl solution between them was collected from the buoyant CsCl-EB gradient.
The solution was diluted with 0.01 M Tris HCl, pH 7.5, 0.001 M EDTA; and the DNA
was pelleted at 45 krpm for 12 hr in a Spinco SW-50 rotor. The M DNA pellet was al-
lowed to resuspend in 0.25-0.5 ml of supernatant and was stored at -20°.
Specimens for electron microscopy were prepared as described earlier2 and were
examined in a Philips EM-300 electron microscope. Classification of M DNA forms
was performed at the microscope by direct observation on the fluorescent screen or on
an auxiliary Plumbicon TV monitor system. The procedures and criteria for classifying
the M DNA forms have been described.5
Results.-The results obtained in this study are presented graphically in a
series of panels which show the M DNA and the leukocyte distributions in each
blood sample. The medical diagnoses and pertinent clinical data supplied to
us by our colleagues are given in Table 1, along with a summary of the M
DNA distributions.
Untreated granulocytic leukemia: Figure 2a presents the M DNA distribution
in the circulating leukocytes from M. C., a patient with chronic granulocytic
leukemia. The circular dimer frequency (31%) did not change significantly
in four analyses during an 18-month period. The frequency of catenated
dimers (7%) is within the range found in normal mammalian tissues (6-9%).5
The frequency of catenated higher oligomers (trimers and larger catenanes)
is significantly higher (8%) than in normal tissues in which the highest frequency
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TABLE 15 Number frequency of complex mitochondrial DNA in leukemic and nonleukemic
patients.
Circular Catenated Catenated
dimer dimer higher oligomer
Patient* Diagnosist Chemotherapy (%) (%) (%)
M. C.a CGL None: 31±4 7±2 8 ±i2
C. H.b AGL None 48 ±t 4§ 4 ± 1§ 5 ± 2§
pj.jb 29 ± 6 6 ± 3 1.0 ± 0.9
M.W.C CGL a 21±3 6±2 3 ±1
Myleran, 3 wk 7 ± 2 7 ± 2 2 i1
M.R.b None 1442 7±2 1 ±0.7
it
"Myleran, l wk 7 4 2 11 ± 2 3 ± 1
t it" 3 wk 5 ± 1 11 ± 2 2 4 1
M. Y.d Myleran, 2 yr 2 ± 1 4 ± 2 2 ±1
L. G.b 3 yr 2 ± 1 4 ± 1 0.1
L.S.a a 2yr 3±1 541 0.3
A. M.c a a 2wk 6 ±2 5 ±2 1 40.9
A. p.b AGL 6-MP, 8 months** 1 ± 0.8 5 ± 2 0.1
L.J.b "a days 242 542 0.6
R. B.e " 2wk 2 ± 1§ 4 ± 2§ 0.6§
E. F.b At CGL None 12 ± 2 6 ± 2 0.6
J. W.b EaCGL 1 +0.9§ 3 ±2§ 0.9§
M. L.b MM 0 6 ± 1 0.5± 0.3
T. D.b MM 0 4 ± 1 0.8 ± 0.4
M. D.c LR 0 5 ± 1 0.6 ± 0.4
* The diagnoses for the patients were supplied by: (a) H. R. Bierman; (b) R. L. Teplitz; (c) W. C.
Moloney; (d) R. D. Lewis; and (e) R. Boardman.
t CGL, AGL, At CGL, and Ea CGL signify chronic, acute, atypical chronic, and early chronic
granulocytic leukemia, respectively. MM and LR signify myeloid metaplasia and leukomoid
reaction, respectively.
$ This patient was treated periodically by leukophoresis, a procedure in which the patient's red
cells and plasma aie infused after removal of the buffy coat.
§ Data obtained from a lower-band M DNA in a CsCl-EB density gradient.
** This patient also received Vincristine and Methotrexate.
FIG. 2.-The distribution M.G,3 CGL C.H., I AGL
of complex forms in the M 1
DNA obtained from two
granulocytic leukemic pa- MDNA 565 MDNA 558(LB)
tients who had not received 30 WBC 75,000 WBC 325,000- 30
cytotoxic drugs. The M
DNA distribution is given
....in per cent at the left of each 20
panel: Monomers, M; circular
dimers, D; catenated dimers, 10-10
Cd; and catenated higher
oligomers, Co. The leuko-
cyte distribution in per cent c - o....
is given at the right of each M D Cd Co BI Pr MyMe Ly O M D Cd Co BI Pr MyMe Ma Ly O
panel: Myeloblasts, Bi; pro- a b
myelocytes, Pr; myelocytes,
My; metamyelocytes, Me; mature forms, Ma; lymphocytes, Ly; and other types, 0.
The numbers after M DNA and WBC represent the number of DNA molecules classified
and the leukocyte count in cells/mm.3 CGL and AGL stand for chronic and acute granulocytic
leukemia, respectively. The number after the patient's initials is our code number for the
blood sample analyzed. The error bar indicates the interval which contains the true mean
at a level of confidence of 95%. The calculation takes into account only the uncertainty
associated with the finite sample. The symbol LB stands for lower band in the CsCl-EB
gradient. An analysis of a lower band rather than the combination of the upper and lower
bands and the intermediate solution provides a minimum frequency for higher molecular
weight M DNA forms.'
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was 2 per cent.' We calculate that 40 per cent of the M DNA mass is in the
form of circular dimers and that an additional 25 per cent is in the form of
catenated DNA molecules. The catenated higher oligomers were assumed
to be trimers in the foregoing calculation.
The M DNA from C. H., a patient with severe acute granulocytic leukemia,
contained the highest frequency of circular dimers (48%) that we have so far
encountered (Fig. 2b). The catenated higher oligomer frequency (5%) is
again high. The circular dimer accounts for 58 per cent of the mass of the
M DNA, and the catenated form for 17 per cent. The symbol LB in Figure 2b
refers to a lower band in a CsCl-EB density gradient. An analysis of a lower
band yields a minimum estimate of the frequency of higher molecular weight
M DNA, as discussed previously.2 The leukocytes in this blood sample con-
sisted almost entirely of myeloblasts; we may conclude, therefore, that these
blast cells contained the circular dimer and the simple M DNA forms.
The circular dimer frequency in P. J., another untreated patient with the
acute form of the disease, was 29 per cent (Table 1). The per cent leukocyte
distribution was as follows: myeloblasts, 81; promyelocytes, 10; mature forms,
4; lymphocytes, 4; and other types, 1.
Two additional cases of untreated granulocytic leukemia are presented below
in the section on the effects of chemotherapy.
Nonleukemic leukopoietic conditions: Leukocyte distributions similar to those
observed in patients with granulocytic leukemia occur in patients with myeloid
metaplasia and in patients with leukomoid reactions to a variety of stimuli.
Such circulating nonleukemic myeloid cells provide the appropriate controls
for the proposed correlation of the circular dimer M DNA and granulocytic
leukemia. The M DNA's from three such patients are presented in Figure 3.
No circular dimers were detected, even though 1300-2300 molecules were
examined in each sample. The circular dimer level, if not zero, is certainly
less than 0.2 per cent. The catenated dimer and higher oligomer frequencies
are also in the normal range at 4-6 and < 1 per cent, respectively. The leuko-
cyte distributions (Fig. 3a and b) of the two patients with myeloid metaplasia
FIG. 3.-The distribution of complex forms in the M DNA obtained from two patients
with myeloid metaplasia (a and b) and one patient with a leukomoid reaction (c). The symbols
are defined in the legend for Fig. 2.
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are similar to those observed in the blood of patients with chronic granulocytic
leukemia (Figs. 2a, 4, and 5a, and c). We conclude from the above results
that the circular dimer M DNA is not a constituent of normal immature and
mature myeloid cells in man.
The effect of chemotherapy on the M DNA distribution in granulocytic leukemia:
The M DNA from the peripheral blood of a patient with the chronic form of
the disease was examined before and after therapy was initiated with the alkylat-
ing agent, Myleran-1,4 bis[methane sulfonoxyl]butane. The circular dimer
frequency, which was 21 per cent before treatment began, dropped to 7 per cent
after three weeks of chemotherapy (Fig. 4). A similar effect of chemotherapy
was observed in a serial study of theM DNA from patient M. R. (Table 1).
The effect of treatment is illustrated further by the low levels of the circular
dimer in blood samples taken from six granulocytic leukemic patients who
had received cytotoxic drugs for various periods of time (Fig. 5 and Table 1).
The circular dimer frequency in these samples6 ranged from 1 to 3 per cent,
in contrast to the five untreated leukemics (Table 1) in which the circular dimer
frequency ranged from 14 to 48 per cent. The above effects of chemotherapy
were observed consistently, although the patients had widely different leukocyte
distributions.
L. J., a patient with acute granulocytic leukemia, had received the base
analogue 6-mercaptopurine (6-MP) daily for only five days when the blood
sample was taken for analysis (Fig. 5e). The white-cell distribution, which
consisted almost entirely of myeloblasts, had not yet changed in response to
therapy. The circular dimer level (2%) was, however, much lower than that
in C. H., an untreated patient with the same form of the disease (Fig. 2b) whose
leukocyte distribution was similar. These results raise the interesting possibility
that the drug had caused selective removal of the circular dimer from the pe-
ripheral leukocytes; alternatively, a new population of blast cells with a low
level of circular dimers had replaced the original population.
Atypical and early granulocytic leukemia: Patient E. F. (Fig. 6a) was diag-
nosed as an atypical granulocytic leukemic because the patient did not respond
to Myleran in 1963, and bone marrow metaphase spreads did not contain the
partially deleted chromosome 21 (the Philadelphia chromosome) usually
present in chronic granulocytic leukemia.7 On the other hand, the low level of
FIG. 4.-The distribution 30
of complex forms in the M
DNA obtained from a patient
with chronic granulocytic leu- 20
kemia before and after treat-
ment with Myleran for three
weeks. The symbols are de- 10
fined in the legend for Fig. 2.
0
M.W.,1 BEFORE MYLERAN M.W, 2 AFTER MYLERAN 3 wks.
7 IU846
MDNA 742 MDNA 673
WBC 177,000 WBC 18,000
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FIG. 5.-The distribution of complex forms in the M DNA obtained from three patients
with chronic granulocytic leukemia (a, b, and c) and three patients with the acute form of the
disease (d, e, and f) after chemotherapy. The symbols are defined in the legend for Fig. 2.
leukocyte alkaline phosphatase that is normally seen in this form of the disease
was reported. The circular dimer frequency was 12 per cent. The Philadelphia
(Ph') chromosome was found in about half the bone marrow metaphase spreads of
another chronic leukemic patient (J. W.) diagnosed as an early granulocytic
leukemic. The M DNA in the peripheral leukocytes contained 1 per cent circu-
lar dimers.
E.F., 1 1.WI
% E- E U2 %
MDNA 717 MDNA 384(LB)
30- WBC 37,000 WBC 63,000 30 FIG. 6.-The distribution
of complex forms in the M
DNA obtained from un-
20 20 treated patients with (a)
atypical and (b) early chronic
granulocytic leukemia. The
10 12: 0symbols are defined in the
legend for Fig. 2.
C
sA , el A Of D, KA., KA- gA Lnt A rA r, A D KA, K" KA, J)M D Cd Co BaPr My Me MO Ly c M vLa GO t1 Vr My Me Ma Ly V
a .b
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Discussion.-Circular dimer M DNA is present in all the granulocytic leu-
kemics that we have studied to date (Table 1). The highest frequency of
circular dimers (48%) was found in a case of untreated acute granulocytic
leukemia with leukocytes that contained 98 per cent myeloblasts. High
frequencies of circular dimers (31 and 21%) were also observed in two cases
of untreated chronic granulocytic leukemia with moderately immature leukocyte
distributions. In the chronic leukemic patients with moderately mature leuko-
cyte distributions, the frequency of circular dimers was lower: 14 per cent
in an untreated case, 12 per cent in an atypical case, and 1 per cent in an early
case. The above preliminary correlation of the circular dimer frequency with
the immaturity of the leukocyte distribution suggests that the circular dimer
frequency is related to the severity of the disease.
The effect of chemotherapy upon the circular dimer level in acute granulocytic
leukemia may be dramatic: The level in two patients who had been under
treatment for two weeks or less was 2 per cent, and in another, under chemo-
therapy for eight months, the level was 1 per cent. A drastic reduction in the
circular dimer level must have occurred if it is assumed that the circular dimer
levels in these patients were initially as high as in patient C. H. Serial studies
are required to substantiate this reasoning.
The effect of chemotherapy upon the level of circular dimers in cases of
chronic granulocytic leukemia was less pronounced. The circular dimer level
was 2-3 per cent in three patients under long-term treatment with Myleran.
It was 5-7 per cent in the M DNA from three patients who had received Myleran
for periods of two to three weeks.
While the gene products of the M DNA in animal cells have not as yet been
established, the DNA itself is known to be metabolically active. In HeLa
cells it serves as a template for a rapidly labeled heterogeneous RNA found
in the mitochondria and associated with the rough endoplasmic reticulum.8'
The above observations, together with the report by Woodward and Munkres
that a membrane structural protein is altered in a cytoplasmic mutant of
Neurospora," raise the possibility that membrane structural proteins are among
the gene products of M DNA in animal cells. A defect in the regulation or the
structure of such proteins in cells containing the circular dimer could contribute
to the physiological properties characteristic of the neoplastic cells. A review of
the evidence for a membrane theory of cancer has appeared recently." At the
present time we do not know whether the M DNA abnormality is an early event
in the disease or a consequence of other events which change the physiology of the
cell so as to permit the proliferation of the dimerM DNA form.
We noted earlier'2 that the formation of catenanes or circular dimers from
circular monomers necessarily involves the cell's machinery for opening and
closing the backbone chains of DNA. The various enzyme systems-enzymes,
regulators, and enzyme sites-involved in DNA synthesis, recombination,
and repair are thus candidates for the specific aberrations which result in the
formation of the abnormal circular dimer M DNA.
Closed circular dimers and higher circular oligomers also occur as intracellular
viral forms in infected bacteria'3 and animal cells,'4 and as plasmids and episomes
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in bacteria.15' 16 These simpler experimental systems may be expected to be
useful in elucidating the detailed mechanism of the formation of dimers from
monomers.17, 18
Abnormal M DNA represents the second kind of aberration to have been
detected in the genetic apparatus of leukemic myeloid cells. A partially
deleted chromosome, Ph', is usually present in metaphase spreads of bone
marrow cells from patients with chronic granulocytic leukemia. Aneuploidy
often occurs in the cells of chronic granulocytic leukemic patients after the acute
transformation of the disease has taken place,"9 and in the cells of patients with
acute granulocytic leukemia. The relationship between the above chromosomal
anomalies and the mitochondrial DNA anomaly is one of many problems raised
by the results described in this communication.
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